The NIH's National Institute of Allergy and Infectious Diseases awarded a contract to Unither Virology, a unit of United Therapeutics, to help it develop an antiviral treatment for flu, dengue and other types of viruses using the subsidiary's glycobiology antiviral technology. Unither is expected to create about 20 jobs in Silver Spring, Md., and will receive about $10.6 million for a period of 42 months under the federal contract.

Related Summaries